nongerminomatous germ cell tumor
nongerminomatous germ cell tumor
Explore linked clinical trials. Standard reference: MONDO:00216564 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | Female Urogenital Diseases and Pregnancy Complications, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, Pregnancy Complications, Neoplastic, Urogenital Diseases, adenocarcinoma, carcinoma, choriocarcinoma, epithelial neoplasm, extragonadal seminoma, germinoma, malignant germ cell tumor, mesonephric neoplasm, mixed germ cell tumor, neoplasm, nongerminomatous germ cell tumor, pregnancy disorder, seminoma, teratoma, trophoblastic neoplasm, yolk sac tumor | Active, not recruiting | Phase 3 | 2026-06-16 | NCT02375204 | |
| Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, neoplasm, nongerminomatous germ cell tumor, ovarian germ cell tumor | Recruiting | Phase 2 | 2026-05-08 | NCT04804007 | |
| A Phase II Trial of Cabozantinib With Patients With Refractory GCTs | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, germinoma, neoplasm, nongerminomatous germ cell tumor, ovarian germ cell tumor, seminoma | Active, not recruiting | Phase 2 | 2026-01-15 | NCT04876456 | |
| Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors | Nonseminomatous germ cell tumor, nongerminomatous germ cell tumor | Recruiting | Not applicable | 2025-05-08 | NCT05705687 |